These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10891591)

  • 21. AP-1 DNA binding activity induced by hyperosmolality in the rat hypothalamic supraoptic and paraventricular nuclei.
    Ying Z; Reisman D; Buggy J
    Brain Res Mol Brain Res; 1996 Jul; 39(1-2):109-16. PubMed ID: 8804719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AP-1 activation and altered AP-1 composition in association with increased phosphorylation and expression of specific Jun and Fos family proteins induced by vinblastine in KB-3 cells.
    Berry A; Goodwin M; Moran CL; Chambers TC
    Biochem Pharmacol; 2001 Sep; 62(5):581-91. PubMed ID: 11585055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary energy restriction, in part through glucocorticoid hormones, mediates the impact of 12-O-tetradecanoylphorbol-13-acetate on jun D and fra-1 in Sencar mouse epidermis.
    Przybyszewski J; Wang W; Au A; Perry C; Guetzko M; Koehler K; Birt DF
    Mol Carcinog; 2010 Jun; 49(6):592-602. PubMed ID: 20232358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activator protein-1 complex expressed by magnetism in cultured rat hippocampal neurons.
    Hirai T; Nakamichi N; Yoneda Y
    Biochem Biophys Res Commun; 2002 Mar; 292(1):200-7. PubMed ID: 11890693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
    Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
    Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic antipsychotic drug treatment induces long-lasting expression of fos and jun family genes and activator protein 1 complex in the rat prefrontal cortex.
    Kontkanen O; Lakso M; Wong G; Castrén E
    Neuropsychopharmacology; 2002 Aug; 27(2):152-62. PubMed ID: 12093589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Fos-related antigen-1 in head and neck squamous cell carcinoma.
    Mangone FR; Brentani MM; Nonogaki S; Begnami MD; Campos AH; Walder F; Carvalho MB; Soares FA; Torloni H; Kowalski LP; Federico MH
    Int J Exp Pathol; 2005 Aug; 86(4):205-12. PubMed ID: 16045542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fos- and Jun-related transcription factors are involved in the signal transduction pathway of mechanical loading in condylar chondrocytes.
    Papachristou D; Pirttiniemi P; Kantomaa T; Agnantis N; Basdra EK
    Eur J Orthod; 2006 Feb; 28(1):20-6. PubMed ID: 16373449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-dose and chronic corticosterone treatment alters c-Fos or FosB immunoreactivity in the rat cerebral cortex.
    Szakács R; Fazekas I; Mihály A; Krisztin-Péva B; Juhász A; Janka Z
    Acta Histochem; 2010 Mar; 112(2):147-60. PubMed ID: 19100597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of mild traumatic brain injury on immunoreactivity for the inducible transcription factors c-Fos, c-Jun, JunB, and Krox-24 in cerebral regions associated with conditioned fear responding.
    Abrous DN; Rodriguez J; le Moal M; Moser PC; Barnéoud P
    Brain Res; 1999 May; 826(2):181-92. PubMed ID: 10224295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility.
    Tkach V; Tulchinsky E; Lukanidin E; Vinson C; Bock E; Berezin V
    Oncogene; 2003 Aug; 22(32):5045-54. PubMed ID: 12902987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of cycloheximide on the regulation of proenkephalin and prodynorphin gene expressions induced by kainic acid in rat hippocampus.
    Won JS; Kim YH; Song DK; Suh HW
    Brain Res Mol Brain Res; 1997 Jul; 47(1-2):303-10. PubMed ID: 9221929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Difference in transcriptional regulatory function between c-Fos and Fra-2.
    Suzuki T; Okuno H; Yoshida T; Endo T; Nishina H; Iba H
    Nucleic Acids Res; 1991 Oct; 19(20):5537-42. PubMed ID: 1945831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat.
    Bronstein DM; Ye H; Pennypacker KR; Hudson PM; Hong JS
    Brain Res Mol Brain Res; 1994 May; 23(3):191-203. PubMed ID: 7914658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spatial and temporal profile of haloperidol-induced immediate-early gene expression and phosphoCREB binding in the dorsal and ventral striatum of amphetamine-sensitized rats.
    Hsieh HC; Li HY; Lin MY; Chiou YF; Lin SY; Wong CH; Chen JC
    Synapse; 2002 Sep; 45(4):230-44. PubMed ID: 12125044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Light-induced variations in AP-1 binding activity and composition in the rat suprachiasmatic nucleus.
    François-Bellan AM; Deprez P; Becquet D
    J Neurochem; 1999 Feb; 72(2):841-7. PubMed ID: 9930761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of REM sleep to Fos and FRA expression in the vestibular nuclei of rat leading to vestibular adaptation during the STS-90 Neurolab Mission.
    Pompeiano O
    Arch Ital Biol; 2007 Jan; 145(1):55-85. PubMed ID: 17274184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Learning-specific, time-dependent increases in hippocampal Ca2+/calmodulin-dependent protein kinase II activity and AMPA GluR1 subunit immunoreactivity.
    Cammarota M; Bernabeu R; Levi De Stein M; Izquierdo I; Medina JH
    Eur J Neurosci; 1998 Aug; 10(8):2669-76. PubMed ID: 9767396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts.
    Lallemand D; Spyrou G; Yaniv M; Pfarr CM
    Oncogene; 1997 Feb; 14(7):819-30. PubMed ID: 9047389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. fra-2 promoter can respond to serum-stimulation through AP-1 complexes.
    Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H
    Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.